Clinical Trials Directory

Trials / Completed

CompletedNCT01940380

The Study of LTBP1 of Postmenopausal Women Osteoporosis Molecular Mechanism of Kidney Yang Deficiency Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
25 (estimated)
Sponsor
Fujian Academy of Traditional Chinese Medicine · Academic / Other
Sex
Female
Age
45 Years – 75 Years
Healthy volunteers
Accepted

Summary

Postmenopausal Osteoporosis is characterized by a decrease in bone mass as well as a deterioration of the bone architecture resulting in an increased risk of fracture,which is directly related to the lack of estrogen and also associated with a variety of genetic and acquired factors. Previous studies have found that POP molecular regulation mechanism of kidney Yang deficiency syndrome may be associated with LTBP1 gene expression. This topic using RT-PCR and Western Blot detection POP of kidney Yang deficiency group and healthy group LTBP1 mRNA and proteion's expression level,validate LTBP1 relevance to POP the kidney Yang deficiency syndrome.To provide a scientific basis for clinical treatment.

Conditions

Timeline

Start date
2013-09-01
Primary completion
2013-12-01
Completion
2016-12-09
First posted
2013-09-12
Last updated
2017-03-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01940380. Inclusion in this directory is not an endorsement.